Key Highlights
•
Delaying surgery for chronic subdural hematoma (a blood clot on the brain) significantly worsens a patient’s recovery. For each day surgery is postponed, the risk of a poor functional outcome increases, with the risk rising by up to 28% after a 30-day wait.
Source →
•
The study found that older patients, those on antiplatelet medications (like aspirin), and those with milder symptoms were more likely to experience surgical delays. This highlights specific patient groups where hospital systems need to streamline care to prevent worse outcomes from a common brain condition.
Source →
•
A new imaging probe that targets the estrogen receptor and works in the near-infrared range shows promise for detecting breast tumors. This technology could allow surgeons to better see tumor boundaries during operations, potentially leading to more precise and complete cancer removal.
Source →
•
The probe is designed for “image-guided surgery,” meaning it provides real-time visual feedback to surgeons. This represents an advance in precision medicine, aiming to improve outcomes for breast cancer patients by ensuring no cancerous tissue is left behind.
Source →
•
In patients with Still’s disease, high levels of a protein called interleukin-18 (IL-18) can predict a more severe and long-lasting disease course. Checking IL-18 levels, especially three months after starting treatment, helps identify patients who may need their therapy adjusted early on.
Source →
•
Elevated IL-18 is also linked to a higher risk of developing a dangerous complication called macrophage activation syndrome. This finding provides doctors with a simple blood test to better stratify risk and personalize treatment for this inflammatory disorder.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
